Archive

Microchip Purchase of Microsemi Gets Thumbs Up From Wall Street

Mizuho | Investor's Business Daily

ViewPoints: Ionis unveils the next best thing in Huntington’s disease

Mizuho | FirstWord Pharma

Dermira set to end development of olumacostat glasaretil after failure of two late-stage acne studies

Mizuho | FirstWord Pharma

Dermira Acne Drug Failure: What Biotech Binary Means

Mizuho | Bloomberg Quint

Dermira Reminds Investors What Binary Means in Biotech

Mizuho | Bloomberg Gadfly

Novel Acne Drug to Be Abandoned

Mizuho | MedPage Today

Dermira to abandon Acne Drug, Shares Crater

Mizuho | Reuters

Tech Today: Nasdaq Down 1%, Pondering VMware, Handicapping Broadcom

Mizuho | Barron's

Shares of virtualization pioneer VMware (VMW) are down $7.64, or 6%, at $116.02, despite the company yesterday afternoon beating fiscal Q4 expectations, and affirming its outlook: as William Blair’s Jason Ader writes, it was a “strong” report, but it doesn’t really matter. “VMware stock has now become event-driven,” with Michael Dell’s rumored interest in conducting a reverse merger. “The strong current fundamentals matter less,” he concludes.

Broadway Technology Connects to Moscow Exchange

Broadway Technology | Finextra

Moscow Exchange Expands Access to its FX Market for International Investors

Broadway Technology | MondoVisione